Murine model for pertussis vaccine encephalopathy role of the major histocompatibility complex antibody to albumin and to bordetella pertussis and pertussis toxin
Falkow, S.
International Association Of Biological Standardization (edelopments In Biological Standardization, Vol. 61. Pertussis; Joint Meeting Of The International Association Of Biological Standardization And Who, Geneva, Switzerland, Sept. 25-27, . Xii 594p. S. Karger Ag: Basel, Switzerland; New York, N.y., Usa. Illus. Paper. 439-446, 1985
1986
Accession: 028758442
PDF emailed within 1 workday: $29.90
Related References
Steinman, L.; Weiss, A.; Adelman, N.; Lim, M.; Oehlert, J.; Zuniga, R.; Hewlett, E.; Falkow, S. 1985: Murine model for pertussis vaccine encephalopathy: role of the major histocompatibility complex; antibody to albumin and to Bordetella pertussis and pertussis toxin Developments in Biological Standardization 61: 439-446Gzyl, A. 2004: Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960Efficiency of the DtwP vaccine-induced immunity against currently circulating B. pertussis isolates Vaccine 22(17-18): 2122-2128
Gzyl, A.; Augustynowicz, E.; Gniadek, G.; Rabczenko, D.; Dulny, G.; Slusarczyk, J. 2004: Sequence variation in pertussis S1 subunit toxin and pertussis genes in Bordetella pertussis strains used for the whole-cell pertussis vaccine produced in Poland since 1960: efficiency of the DTwP vaccine-induced immunity against currently circulating B. pertussis isolates Vaccine 22(17-18): 2122-2128
Dalby, T.; Petersen, J.W.; Harboe, Z.B.; Krogfelt, K.A. 2010: Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine Journal of Medical Microbiology 59(Part 9): 1029-1036
Oda, M.; Morikawa, K. 1995: Protective activity of filamentous hemagglutinin and pertussis toxin of Bordetella pertussis as judged by mouse protection test using B pertussis mutant and acellular pertussis vaccine Abstracts of the General Meeting of the American Society for Microbiology 95: 236
Cheung, G.Y.C.; Xing, D.; Prior, S.; Corbel, M.J.; Parton, R.; Coote, J.G. 2006: Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model Infection and Immunity 74(12): 6797-6805
Marsili, I.; Pizza, M.; Giovannoni, F.; Volpini, G.; Bartalini, M.; Olivieri, R.; Rappuoli, R.; Nencioni, L. 1992: Cellular pertussis vaccine containing a Bordetella pertussis strain that produces a nontoxic pertussis toxin molecule Infection and Immunity 60(3): 1150-1155
Gupta, R.K. 1991: Detoxification of Bordetella pertussis organisms or pertussis toxin with glutaraldehyde for preparation of pertussis vaccine Vaccine 9(9): 690-691
Thomas, M.G.; Ashworth, L.A.; Miller, E.; Lambert, H.P. 1989: Serum IgG, IgA, and IgM responses to pertussis toxin, filamentous hemagglutinin, and agglutinogens 2 and 3 after infection with Bordetella pertussis and immunization with whole-cell pertussis vaccine Journal of Infectious Diseases 160(5): 838-845
Nadia Khelef; Nicole Guiso 1993: In Vivo Role of Adenylate Cyclasehemolysin, Pertussis Toxin, Filamentous Hemagglutinin, Agglutinogens and Pertactin during Bordetella pertussis Infection Using a Murine Respiratory Model Biologicals 21(1): 16-0
Alexander, F.; Matheson, M.; Fry, N.K.; Labram, B.; Gorringe, A.R. 2012: Antibody responses to individual Bordetella pertussis fimbrial antigen Fim2 or Fim3 following immunization with the five-component acellular pertussis vaccine or to pertussis disease Clinical and Vaccine Immunology: Cvi 19(11): 1776-1783
Ausiello, C.M.; Lande, R.; Urbani, F.; Di Carlo, B.; Stefanelli, P.; Salmaso, S.; Mastrantonio, P.; Cassone, A. 2000: Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine Journal of Infectious Diseases 181(6): 1989-1995
Podda, A.; Bona, G.; Canciani, G.; Pistilli, A.M.; Contu, B.; Furlan, R.; Meloni, T.; Stramare, D.; Titone, L.; Rappuoli, R. 1995: Effect of priming with diphtheria and tetanus toxoids combined with whole-cell pertussis vaccine or with acellular pertussis vaccine on the safety and immunogenicity of a booster dose of an acellular pertussis vaccine containing a genetically inactivated pertussis toxin in fifteen- to twenty-one-month-old children. Italian Multicenter Group for the Study of Recombinant Acellular Pertussis Vaccine Journal of Pediatrics 127(2): 238-243
Hausman, S.Z.; Burns, D.L. 2000: Use of pertussis toxin encoded by ptx genes from Bordetella bronchiseptica to model the effects of antigenic drift of pertussis toxin on antibody neutralization Infection and Immunity 68(6): 3763-3767
Ennis, D.P.; Cassidy, J.P.; Mahon, B.P. 2005: Acellular pertussis vaccine protects against exacerbation of allergic asthma due to Bordetella pertussis in a murine model Clinical and Diagnostic Laboratory Immunology 12(3): 409-417
Watanabe, M.; Nagai, M. 2002: Effect of acellular pertussis vaccine against various strains of Bordetella pertussis in a murine model of respiratory infection Journal of Health Science 48(6): 560-564
Romani, T.; Lynn, F.; Meade, B.; Arciniega, J. 1997: Restoration of virulence of a pertussis toxin minus mutant of Bordetella pertussis by systemically administered PT in the murine intracerebral infection model Abstracts of the General Meeting of the American Society for Microbiology 97: 100
Sompagdee, N.; Anuwutnavin, S.; Phongsamart, W.; Senawong, S.; Umrod, P.; Robkhonburi, A. 2020: Seroprevalence of Bordetella pertussis antibodies and anti-pertussis antibody response after a single dose of reduced-antigen combined diphtheria, tetanus, and acellular pertussis vaccine (Tdap) in pregnant Thai women Vaccine 38(12): 2725-2733
Kang, K.R.; Huh, D.H.; Kim, J.A.; Kang, J.H. 2021: Immunogenicity of a new enhanced tetanus-reduced dose diphtheria-acellular pertussis (Tdap) vaccine against Bordetella pertussis in a murine model Bmc Immunology 22(1): 68
Kwon, H.J.; Han, S.B.; Kim, B.R.; Kang, K.R.; Huh, D.H.; Choi, G.S.; Ahn, D.H.; Kang, J.H. 2017: Assessment of safety and efficacy against Bordetella pertussis of a new tetanus-reduced dose diphtheria-acellular pertussis vaccine in a murine model Bmc Infectious Diseases 17(1): 247